Heritage Property - challenges and opportunities in the era of smart buildings
How are moves towards ever smarter buildings affecting heritage property?
Digital advances are having an enormous impact on our built environment. Buildings can now accommodate user demand for preferred temperatures, lighting levels and air-conditions. Owners and occupiers can capture data in order to track retail trends, measure building performance or benchmark efficiency and productivity.
Occupiers are increasingly seeking greater flexibility in their use of buildings - more social sharing of space and temporary work environments.
Such demands can be more easily addressed in new developments but what about older buildings? Historic and listed buildings still comprise a considerable proportion of our built environment. How is heritage property adapting to the new demands? Do heritage buildings provide opportunities or just challenges in our modern world?
Charles Russell Speechlys have brought together four distinquished experts in this field to take part in a breakfast forum:
- Duncan McCallum – Policy Director - Historic England
- Tim Hyman – Design Manager – Derwent London
- Mark Tredwell – Project Director – Estate Development Programme – Grosvenor
- Stuart Wilson – Director of Operations, UK & Ireland – WiredScore
Our speakers will explain the approaches of their organisations and debate with our invited audience the challenges and opportunities provided by heritage property in an evolving built environment .
To register your interest please click the register button below or contact our Events Team for further information.
Date / Time: 11 October 2017 / 08:00 - 10:00
News & Insights
It's About Time!
The industry’s holy trinity of time, cost and quality is well known and yet unlocking the treatment of delay remains a continual challenge.
Charles Russell Speechlys advises Kreos and SVB on £20m growth capital investment to Mereo BioPharma
We advised Kreos Capital and Silicon Valley Bank on the refinancing of £20 million growth capital investment to Mereo BioPharma Group